Corcept Therapeutics Inc. Announces Commencement of Next Phase 3 ...
Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of GR-II antagonist drugs for the treatment of severe psychiatric
...
http://www.biospace.com/news_story.aspx?NewsEntityId=90258...
|
Corcept Therapeutics Announces Commencement of a Phase 3 Trial for ...
Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and metabolic ...
http://biz.yahoo.com/iw/071219/0341695.html...
|
Corcept Therapeutics Inc. Announces Negative Results From The ...
These include information relating to Corcept's PMD clinical development program , the timing of the completion of its remaining pivotal Phase 3 trial and ...
http://www.biospace.com/news_story.aspx?NewsEntityId=31614...
|
Corcept Preclinical Trials Show Corlux(R) Prevents Weight Gain ...
INTELLECTUAL PROPERTY PORTFOLIO Corcept's primary activity continues to be the development of CORLUX, for the treatment of the psychotic symptoms of ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
Eli Lilly and Company To Support Corcept Therapeutics Inc.'s ...
Corcept's primary activity continues to be the development of CORLUX for the treatment of the psychotic symptoms of psychotic major depression (PMD). ...
http://www.biospace.com/news_story.aspx?NewsEntityId=179...
|
Corcept Therapeutics Completes $25 Million Private Equity ...
MENLO PARK, CA--(MARKET WIRE)--Mar 26, 2008 -- Corcept Therapeutics ... to continue development of its proprietary, selective GR-II antagonists and for ...
http://biz.yahoo.com/iw/080326/0379691.html...
|
Corcept Therapeutics Inc. Announces Phase 3 Study Evaluating ...
These include information relating to Corcept's PMD clinical development program and the timing of the completion of Phase 3 trials. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=49620...
|
Argenta Discovery Announces Collaboration with US Pharmaceutical ...
Corcept Therapeutics, Inc. is a development stage pharmaceutical company located in Menlo Park, California. It is engaged in the discovery, development and ...
http://www.argentadiscovery.com/news/press_releases/archive/...
|
Research costs lead to bigger 2Q loss for Corcept: Financial News ...
(AP) -- Drug developer Corcept Therapeutics Inc. posted a bigger second-quarter loss as it continued development of its drug candidates. ...
http://biz.yahoo.com/ap/080814/earns_corcept.html?.v=1...
|
Pharmaceutical Collaborations 2008 – an SMi conference
Paul Clewlow, Senior VP of Business Development at Argenta,. discussed an encounter between Argenta and Corcept. Therapeutics Inc at a conference. ...
http://www.biomedcentral.com/content/pdf/cd-900110.pdf...
|
